Avutometinib

avutometinib · Verastem, Inc.

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for Avutometinib, covering 2024-01-12 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer [Phase 2]